cytarabine

Trials studying cytarabine

• phase1A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapiesactive not recruitingn=196
• phase2A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemiaactive not recruitingn=39
• phase1Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AMLrecruitingn=125
• phase2Lazarus: IT Therapy for ICANSnot yet recruitingn=59
• phase2Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL)active not recruitingn=543
• phase1Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemiarecruitingn=24
• phase1Combination Chemotherapy (FLAG-Ida) With Pivekimab Sunirine (PVEK) for the Treatment of Newly Diagnosed Adverse Risk Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasmsactive not recruitingn=30
• phase2Response-adapted Luvometinib With or Without Cytarabine in Langerhans Cell Histiocytosisnot yet recruitingn=30